Hoth Therapeutics (NASDAQ:HOTH) Given “Buy” Rating at D. Boral Capital
Hoth Therapeutics (NASDAQ:HOTH – Get Free Report)‘s stock had its “buy” rating reiterated by D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $5.00 target price on the stock. D. Boral Capital’s price target would suggest a potential upside of 342.48% from the company’s current […]
Hoth Therapeutics (NASDAQ:HOTH – Get Free Report)‘s stock had its “buy” rating reiterated by D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $5.00 target price on the stock. D. Boral Capital’s price target would suggest a potential upside of 342.48% from the company’s current […]
